← Leaderboards
Earl Ray Dorsey
University Of Rochester
$5,129,099
Attributed
$8,190,109
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2015–22$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$17,350,202 · 5
By mechanism
P50$12,501,361 · 3
U01$4,081,347 · 1
P20$767,494 · 1
Top collaborators
- Michael A Schwarzschild6 shared
- Tanya Simuni Simuni6 shared
- Lara M Mangravite5 shared
- Solveig Sieberts1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Robert G. Holloway$15,952,435
- Dana B Mukamel$14,980,784
- Geoffrey C Williams$6,710,843
- Sean Michael Frey$2,111,425
- Timothy D Dye$4,309,052
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyResearch PersonnelCellular PhoneParticipantVirtualNovel StrategiesResourcesParkinson DiseaseClinical TrialsDisease ProgressionCaringUniversitiesMotorScientistComputersInfrastructurePersonsClinicResearch StudyGrantSensorMultidisciplinaryDisease ModelClinical Research
Grant awards (23)
Morris K. Udall Center at the University of Rochester (UR-Udall Center)$1,812,245
P50 · FY2022 · NS · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$774,161
U01 · FY2022 · NS
Research Project 4 will develop novel, objective, and passive measures of Parkinson disease features$426,374
P50 · FY2022 · NS · contact PI
The Administrative Core will support Udall Center activities at the University of Rochester$293,142
P50 · FY2022 · NS · contact PI
Morris K. Udall Center at the University of Rochester (UR-Udall Center)$1,812,624
P50 · FY2021 · NS · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$778,151
U01 · FY2021 · NS
Research Project 4 will develop novel, objective, and passive measures of Parkinson disease features$430,186
P50 · FY2021 · NS · contact PI
The Administrative Core will support Udall Center activities at the University of Rochester$280,239
P50 · FY2021 · NS · contact PI
Morris K. Udall Center at the University of Rochester (UR-Udall Center)$1,804,458
P50 · FY2020 · NS · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$786,024
U01 · FY2020 · NS
Research Project 4 will develop novel, objective, and passive measures of Parkinson disease features$411,409
P50 · FY2020 · NS · contact PI
The Administrative Core will support Udall Center activities at the University of Rochester$244,387
P50 · FY2020 · NS · contact PI
Morris K. Udall Center at the University of Rochester (UR-Udall Center)$1,825,204
P50 · FY2019 · NS · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$790,164
U01 · FY2019 · NS
Research Project 4 will develop novel, objective, and passive measures of Parkinson disease features$438,726
P50 · FY2019 · NS · contact PI
The Administrative Core will support Udall Center activities at the University of Rochester$272,358
P50 · FY2019 · NS · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$100,000
U01 · FY2019 · NS
Morris K. Udall Center at the University of Rochester (UR-Udall Center)$1,905,562
P50 · FY2018 · NS · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$852,847
U01 · FY2018 · NS
The Administrative Core will support Udall Center activities at the University of Rochester$272,224
P50 · FY2018 · NS · contact PI
Research Project 4 will develop novel, objective, and passive measures of Parkinson disease features$272,223
P50 · FY2018 · NS · contact PI
Developing, evaluating, and disseminating new methods and technologies to advance Parkinson disease research$383,747
P20 · FY2016 · NS · contact PI
Developing, evaluating, and disseminating new methods and technologies to advance Parkinson disease research$383,747
P20 · FY2015 · NS · contact PI